Total planned funding: $183,713,658
Allocations
Countries/Regions
Ukraine | $183,713,658 |
Organizational Types
Unknown | $55,076,354 |
NGO | $46,168,932 |
Private Contractor | $22,944,905 |
Own Agency | $21,992,489 |
Multi-lateral Agency | $13,489,021 |
University | $12,266,234 |
Other USG Agency | $6,125,723 |
Implementing Agency | $5,400,000 |
Host Country Government Agency | $250,000 |
Program Areas
Governance and Systems | $76,460,586 |
Testing | $32,978,909 |
Treatment | $28,065,518 |
Prevention | $18,685,137 |
Management and Operations | $14,210,863 |
Care | $13,312,645 |
Budget Codes
OHSS: Health Systems Strengthening | $42,794,909 |
HVCT: Testing: HIV Testing and Counseling | $32,978,909 |
HTXS: Treatment: Adult Treatment | $24,301,523 |
HVSI: Strategic Information | $20,498,079 |
HVMS: Management and Operations | $14,210,863 |
HLAB: Laboratory Infrastructure | $13,167,598 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $9,033,661 |
HVTB: Care: TB/HIV | $6,634,655 |
HVOP: Sexual Prevention: Other Sexual Prevention | $6,390,790 |
HBHC: Care: Adult Care and Support | $4,339,356 |
HTXD: Treatment: ARV Drugs | $3,763,995 |
HMBL: Biomedical Prevention: Blood Safety | $2,570,435 |
HKID: Care: Orphans and Vulnerable Children | $2,338,634 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $293,357 |
HMIN: Biomedical Prevention: Injection Safety | $250,000 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $146,894 |
PDTX: Treatment: Pediatric Treatment | $0 |
PDCS: Care: Pediatric Care and Support | $0 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $0 |
Top Partner Programs
Not Available:
$39,151,495
Countries/Regions
USG Aggregated Agencies:
$14,284,103
Countries/Regions
Deloitte Consulting Limited:
$10,625,011
Countries/Regions
University of Washington:
$10,267,000
Countries/Regions